Company News For Sep 4, 2019

Zacks Equity Research Published on September 04, 2019

Conn's, Inc.’s (CONN - Free Report) shares rose 18.3% after the company reported second quarter fiscal 2020 earnings per share of $0.62, surpassing the Zacks Consensus Estimate of $0.51
The Medicines Company’s shares gained 10.4% after the company reported positive results from its ORION-11 trial at ESC Congress 2019.
Shares of Emergent BioSolutions Inc. (EBS - Free Report) surged 14.5% after the company received a 10-year HHS contract to provide ACAM2000 smallpox vaccines to the U.S. Strategic National Stockpile
Shares of Royal Caribbean Cruises Ltd. (RCL - Free Report) fell 1.4% afterthe reorts surfaced that the company could suffer losses of up to $0.05 a share in the current quarter due to the impact of Hurricane Dorian

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.